| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.006 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.29 | 0.006 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |